Outstanding issues in radiation dose-fractionation studies

International Journal of Radiation Biology

Volumn 73, Issue 4, 1998, Pages 383-394

  Hendry, J H ^a   Mackay, R I ^a   Roberts, S A ^a   Slevin, N J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASTRINGENT AGENT; BIOLOGICAL RESPONSE MODIFIER; BLEOMYCIN; CISPLATIN; CYTOTOXIC AGENT; CYTOTOXIN; FLUOROURACIL; INTERLEUKIN 11; METHOTREXATE; NICOTINAMIDE; NIMORAZOLE; POLYUNSATURATED FATTY ACID; RADIOSENSITIZING AGENT; SUCRALFATE; TRANSFORMING GROWTH FACTOR BETA3;

BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CONFERENCE PAPER; DOSE RESPONSE; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; HYPOXIA; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; TUMOR CELL; TUMOR RESISTANCE; UTERINE CERVIX CARCINOMA;

ANIMALS; ANOXIA; BIOLOGICAL RESPONSE MODIFIERS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MICE; RADIOBIOLOGY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RATS; REFERENCE VALUES; SWINE; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0031946359     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098142211     Document Type: Conference Paper

References (122)

1. AMDUR, R. J., PARSONS, J. T., FITZGERALD, L. T., et al., 1990, The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 19, 1377-1382.
2. ANG, K. K., JIANG, G. L., GUTTENBERGER, R., THAMES, H. D., STEPHENS, L. C., SMITH, C. D. and FENG, Y., 1992, Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiotherapy and Oncology, 25, 287-294.
3. ANSCHER, M. S., KONG, F. M., MARKS, L. B., BENTEL., G. C. and JIRTLE, R. L., 1997, Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 37, 253-258.
4. ARLETT, C. F. and HARCOURT, S., 1980, A survey of radiosensitivity in a variety of human cell strains. Cancer Research, 40, 926-932.
5. AWWAD, H., 1992, Unconventional fractionation studies and Tpot correlation. Seminars in Radiation Oncology, 2, 62-66.
6. BECK-BORNHOLDT, H. P., DUBBEN, H. H., LIERTZ-PETERSEN, C. and WILLERS, H., 1997, Hyperfractionation: where do we stand? Radiotherapy and Oncology, 43, 1-12.
7. pot. International Journal of Radiation Oncology, Biology, Physics, 32, 1539-1541.
8. BENTZEN, S. M., 1992, Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma. International Journal of Radiation Biology, 61, 417-423.
9. BENTZEN, S. M., 1994, Radiobiological considerations in the design of clinical trials. Radiotherapy and Oncology, 32, 1-11.
10. BENTZEN, S. M., 1997, Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiotherapy and Oncology, 43, 121-131.
11. BENTZEN, S. M., OVERGAARD, M., THAMES, H. D., CHRISTENSEN, J. J. and OVERGAARD, J., 1989a, Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. International Journal of Radiation Biology, 56, 711-715.
12. BENTZEN, S. M., OVERGAARD, J., THAMES, H. D., OVERGAARD, M., VEJBY-HANSEN, P., VAN DER MAASE, H. and MADER, J., 1989b, Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology, 16, 169-182.
13. BERNIER, J., THAMES, H. D., SMITH, C. D. and HORIOT, J.-C., 1998, Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiotherapy and Oncology (in press).
14. Board of Faculty of Clinical Oncology, 1996, Guidelines for the Management of the Unscheduled Interruption of Prolongation of a Radical Course of Radiotherapy (London: Royal College of Radiologists).
15. BOLGER, B. S., SYMONDS, R. P., STANTON, P. D., MACLEAN, A. B., BURNETT, R., KELLY, P. and COOKE, T. G., 1996, Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. British Journal of Cancer, 74, 1223-1226.
16. BOURHIS, J., WILSON, G. D., WIBAULT, P., BOSQ, J., CHAVAUDRA, N., JANOT, F., LIBOINSKI, B., ESCHWEGE, F. and MALAISE, E. P., 1993, In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 26, 793-799.
17. CORVO, R., GIARETTI, W., SANGUINETI, G., et al., 1995, In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. Journal of Clinical Oncology, 13, 1843-1850.
18. Cox, J. D., PAJAK, T. F., ASBELL, S., RUSSELL, A. H., PEDERSON, J., BYHARDT, R. W., EMAMI, B. and ROACH, H., 1993, Interruptions of high-dose radiation therapy decrease long-term survival of favourable patients with unrespectable non-small cell carcinoma of the lung: analysis of 1244 cases from three Radiation Therapy Oncology Group (RTOG) trials. International Journal of Radiation Oncology, Biology, Physics, 27, 493-498.
19. DACHS, G. U., PATTERSON, A. V., FIRTH, J. D., RATCLIFFE, P. J., TOWNSEND, K. M., STRATFORD, I. J. and HARRIS, A. L., 1997, Targeting gene expression to hypoxic tumor cells. Nature Medicine, 3, 515-520.
20. DE NEVE, W., LYBEERT, M. L. M., GOOR, C., CROMMELIN, M. A. and RIBOT, J. G., 1995, Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiotherapy and Oncology, 36, 181-188.
21. DISCHE, S., 1991, Accelerated treatment and radiation myelitis. Radiotherapy and Oncology, 1, 1-3.
22. DORR, W., JACUBEK, A., KUMMERMEHR, J., HERRMANN, T. H., DOLLING-JOCHEM, I. and ECKELT, U., 1995, Effects of stimulated repopulation on oral mucositis during conventional radiotherapy. Radiotherapy and Oncology, 37, 100-107.
23. DORR, W. and KUMMERMEHR, J., 1992, Increased radiation tolerance of mouse tongue epithelium after local conditioning. International Journal of Radiation Biology, 61, 369-379.
24. DUNCAN, W., MACDOUGAL, R. H., KERR, G. R. and DOWNING, D., 1996, Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiotherapy and Oncology, 41, 203-207.
25. EMAMI, B., LYMAN, J., BROWN, A., COIA, L., GOITEIN, M., MUNZENRIDER, J. E., SHANK, B., SOLIN, L. J. and WESSON, M., 1991, Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics, 21, 109-122.
26. EPSTEIN, J. B. and WONG, F. L. W., 1994, The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 28, 693-698.
27. FOOTE, R. L., LOPRINZKI, C. L., FRANK, A. R., O'FALLON, J. R., GULAVITA, S., TEWFIK, H. H., RYAN, M. A., EARLE, J. M. and NOVOTNY, P., 1994, Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. Journal of Clinical Oncology, 12, 2630-2633.
28. FORAY, N., BADIE, C., ARLETT, C. F. and MALAISE, E. P., 1997, Comments on the paper: the ATM gene and the radiobiology of ataxia-telangiectasia [letter]. International Journal of Radiation Biology, 71, 449-450.
29. FOWLER, J. F. and LINSTROM, M. J., 1992, Loss of local control with prolongation in radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 23, 457-467.
30. GRAEBER, T. G., OSMANIAN, C., JACKS, T., HOUSMAN, D. E., KOCH, C. J., LOWE, S. W. and GIACCIA, A. J., 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
31. GUPTA, N. K., POINTON, R. C. and WILKINSON, P. M., 1987, A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clinical Radiology, 38, 575-581.
32. GUTTENBERGER, R., THAMES, H. D. and ANG, K. K., 1992, Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations. Radiotherapy and Oncology, 25, 280-286.
33. HALLAHAN, D. E., MAUCERI, H. J., SEUNG, L. P., DUNPHY, E. J., WAYNE, J. D., HANNA, N. N., TOLEDANO, A., HELLMAN, S., KUFE, D. W., WEICHSELBAUM, R. R., 1995, Spatial and temporal control of gene therapy using ionizing radiation. Nature Medicine, 1, 786-791.
34. HAMILTON, C. S., DENHAM, J. W., O'BRIEN, M., OSTWALD, P., KRON, T., WRIGHT, S. and DORR, W., 1996, Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiotherapy and Oncology, 40, 23-40.
35. HANSEN, O., OVERGAARD, J., HANSEN, H. S., OVERGAARD, M., HOYER, M., JORGENSEN, K. E., BASTHOLT, L. and BERTHELSEN, A., 1997, Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumour differentiation. Radiotherapy and Oncology, 43, 47-51.
36. HENDRY, J. H., 1989, Response of human organs to single (or fractionated equivalent) doses of irradiation. International Journal of Radiation Biology, 56, 691-700.
37. HENDRY, J. H., 1992, Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues. Radiotherapy and Oncology, 25, 308-312.
38. HENDRY, J. H., 1994, Biological response modifiers and normal tissue injury after irradiation. Seminars in Radiation Oncology, 4, 123-132.
39. HENDRY, J. H., BENTZEN, S. M., DALE, R. G., FOWLER, J. F., WHELDON, T. E., JONES, B., MUNRO, A. J., SLEVIN, N. J. and ROBERTSON, A. G., 1996, A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clinical Oncology, 8, 297-307.
40. HENDRY, J. H. and MOORE, J. V., 1984, Is the steepness of dose-incidence curves for tumour control or complications due to variation before, or as a result of, irradiation? [letter]. British Journal of Radiology, 57, 1045-1046.
41. HENDRY, J. H., ROBERTS, S. A., SLEVIN, N. J., KEANE, T. J., BARTON, M. B., AGREN-CRONQVIST, A., 1994, Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiotherapy and Oncology, 31, 14-22.
42. HERMANN, T., JAKUBECK, A. and TROTT, K. R., 1994, The importance of the timing of a split in radiotherapy of squamous cell carcinomas of the head and neck. Strahlentherapie und Onkologie, 130, 545-549.
43. HOCKEL, M., KNOOP, C., SCHLENGER, K., VORNDRAN, B., BAUSSMAN, E., KITZE, M., KNAPTSTEIN, P. G. and VAUPEL, P., 1993, Intratumoral p02 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology, 26, 45-50.
44. HOCKEL, M., SCHLENGER, K., ARAL, B., MITZE, M., SCHAFFER, U. and VAUPEL, P., 1996, Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509-4515.
45. HOPEWELL, J. W., VAN DEN AARDWEG, G. J., MORRIS, G. M., REZVANI, M., ROBBINS, M. E., ROSS, G. A., WHITEHOUSE, E. M., SCOTT, C. A. and HORROBIN, D. F., 1994, Amelioration of both early and late radiation-induced damage to pig skin by essential fatty acids. International Journal of Radiation Oncology, Biology, Physics, 30, 1119-1125.
46. HOPEWELL, J. W. and VAN DER KOGEL, A. J., 1988, Volume effects in the spinal cord. British Journal of Radiology, 61, 973-975.
47. HORIOT, J.-C., N'GUYEN, T. and CHENAL, C., 1992, Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of randomized trial of the EORTC cooperative group of radiotherapy. Radiotherapy and Oncology, 25, 231-241.
48. JOHANSEN, J., BENTZEN, S. M., OVERGAARD, J. and OVERGAARD, M., 1996, Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiotherapy and Oncology, 40, 101-109.
49. JOINER, M. C., LAMBIN, P., MALAISE, E. P., ROBSON, T., ARRAND, J. E., SKOV, K. A. and MARPLES, B., 1996, Hypersensitivity in very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutation Research, 358, 171-183.
50. JOINER, M. C. and VAN DER KOGEL, A. J., 1997, The linear quadratic approach to fractionation. In Basic Clinical Radiobiology, edited by G. G. Steel (London: Arnold), p. 106-122.
51. JONES, B., DALE, R. G., BLEASDALE, C., TAN, L. T. and DAVIES, M., 1994, A mathematical model of intraluminal and intracavity brachytherapy. British Journal of Radiology, 67, 805-812.
52. KALLMAN, P., AGREN, A. and BRAHME, A., 1992, Tumour and normal tissue responses to fractionated non-uniform dose delivery. International Journal of Radiation Biology, 62, 249-262.
53. LAI, P. P., PEREZ, C. A., SHAPIRO, S. J. and LOCKETT, M. A., 1990, Carcinoma of the prostate stage B and C: lack of difference of duration of radiotherapy on tumour control and treatment morbidity. International Journal of Radiation Oncology, Biology, Physics, 19, 568-581.
54. LANDUYT, W., FOWLER, J. F., RUIFROK, A., STÜBEN, G., VAN DER KOGEL, A. J. and VAN DER SCHUVEN, E., 1997, Kinetics of repair in the spinal cord of the rat. Radiotherapy and Oncology, 45, 55-62.
55. LEIBEL, S. A., KUTCHER, J., ZELEFSKY, M. J., BURMAN, C. M., MOHAN, R., LING, C. C. and FUKS, Z., 1996, 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan Kettering Cancer Genter. Frontiers in Radiation Therapy and Oncology, 29, 229-237.
56. MACIEJEWSKI, B. and MACIEJEWSKI, S., 1991, Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiotherapy and Oncology, 24, 163-170.
57. MACIEJEWSKI, B., ZAJUSZ, A., PILECKI, B., SWIATNICA, K., DORR, W., KUMMERMEHR, J. and TROTT, K. R., 1991, Acute mucositis in the stimulated oral mucosa of patient during radiotherapy for head and neck cancer. Radiotherapy and Oncology, 22, 7-11.
58. MACKAY, R. I., HENDRY, J. H., MOORE, C. J., WILLIAMS, P. C. and READ, G., 1997, Predicting late rectal complications following prostate confirmal radiotherapy using biologically effective doses and normalized dose-surface histograms. British Journal of Radiology, 70, 517-526.
59. MACKAY, R. I., NIEMIERKO, A., GOITEIN, M. and HENDRY, J. H., 1998, Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiotherapy and Oncology, 46, 215-216.
60. MAKKONEN, T. A., BOSTROM, P., VILJA, P. and JOELSUU, H., 1994, Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. International Journal of Radiation Oncology, Biology, Physics, 30, 177-182.
61. MCMILLAN, T. J., 1996, Gene manipulation in radiotherapy. Lancet, 347, 632.
62. MILLAR, W. T., VAN-DEN-AARDWEG, G. J., HOPEWELL, J. W. and CANNEY, P. A., 1996a, Repair kinetics in pig epidermis: an analysis based on two separate rates of repair. International Journal of Radiation Biology, 69, 123-140.
63. MILLAR, W. T., HENDRY, J. H. and CANNEY, P. A., 1996b, The influence of the number of fractions and bi-exponential repair kinetics on biological equivalence in pulsed brachytherapy. British Journal of Radiology, 69, 457-468.
64. MOORE, J. V., HASLETON, P. S. and BUCKLEY, C. H., 1985, Tumour cords in 52 human bronchial and cervical squamous cell carcinomas: inferences for their cellular kinetics and radiobiology. British Journal of Cancer, 51, 407-413.
65. MOORE, J. V. and WEST, D. C., 1991, Vasculature as a target for anti-cancer therapy. International Journal of Radiation Biology, 60, 1-419.
66. MUNRO, A. J., 1995, An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. British Journal of Cancer, 71, 83-91.
67. NEVALDINE, B., LONGO, J. A. and HAHN, P. J., 1997, The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. Radiation Research 147, 535-540.
68. NICOLAS, N., FINNIE, N. J., CAVAZZANA-CALVO, M., PAPADOPOULO, D., LE DEIST, F., FISCHER, A., JACKSON, S. P. and DE VILLARTAY, J. P., 1996. Lack of detectable defect in DNA double-strand break repair and DNA-dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts. European Journal of Immunology, 26, 1118-1122.
69. NORDSMARK, M., OVERGAARD, M. and OVERGAARD, J., 1996, Pre-treatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology, 41, 31-39.
70. NORMAN, A., KAGAN, A. R. and CHAN, S. L., 1988, The importance of genetics for the optimization of radiation therapy. American Journal of Clinical Oncology, 11, 84-88.
71. OVERGAARD, J. and HORSMAN, M. R., 1997, Overcoming hypoxic cell radioresistance. In Basic Clinical Radiobiology, edited by G. G. Steel (London: Arnold), p. 141-151.
72. OVERGAARD, J., HANSEN, H. S., OVERGAARD, M., BASEHOLT, BERTHELSEN, A. SPECHT, L., LINDELOV, B. and JORGENSEN, K., 1998, A randomised double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in syraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology, 46, 135-146.
73. PEREZ, C. A. and BRADY, L. W., editors, 1992, Principles and Practice of Radiation Oncology, 2nd edn (Philadelphia: Lippincott).
74. PEREZ, C. A., GRIGSBY, P. W., GASTRO-VITA, H. and LOCKETT, M. A., 1995. Carcinoma of the uterine cervix: 1. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 32, 1275-1288.
75. POTTEN, C. S., 1996, Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pre-treatment with interleukin II also increases murine survival time. Stem Cells, 14, 452-459.
76. POTTEN, C. S., BOOTH, D. and HALEY, J. D., 1997, Pre-treatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. British Journal of Cancer, 75, 1454-1459.
77. POWERS, B. E., THAMES, H. D., GILLETTE., S. M., SMITH, C., BECK, E. R. and GILLETTE, E. L., 1998, Volume effects in the irradiated canine spinal cord: do they exist when the probability of injury is low? Radiotherapy and Oncology (in press).
78. ROBERTS, S. A. and HENDRY, J. H., 1993, The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. Radiotherapy and Oncology, 29, 69-74.
79. ROBERTS, S. A. and HENDRY, J. H., 1998, A realistic closed-form radiobiological model of clinical tumour control data incorporating inter-tumour heterogeneity. International Journal of Radiation Oncology, Biology, Physics (in press).
80. ROBERTS, S. A., HENDRY, J. H., BREWSTER, A. E. and SLEVIN, N.J., 1994. The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. British Journal of Radiology, 67, 790-794.
81. ROBERTS, S. A., HENDRY, J. H. and SLEVIN, N. J., 1998, Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets. International Journal of Radiation Oncology, Biology, Physics 39, 1173-1182.
82. ROBERTSON, C., ROBERTSON, A. G., HENDRY, J. H., ROBERTS, S. A., SLEVIN, N. J., DUNCAN, W. B., MACDOUGALL, R. H., KERR, G. R., O'SULLIAN, B. and KEANE, T. J., 1998, Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. International Journal of Radiation Oncology, Biology, Physics (in press).
83. ROBSON, H., SPENCE, K., ANDERSON, E., POTTEN, C. S. and HENDRY, J. H., 1997, The influence of TGF beta-3 on cell cycle kinetics and post-irradiation recovery of normal and malignant colorectal epithelial cells. International Journal of Radiation Oncology, Biology, Physics, 38, 183-190.
84. ROFSTAD, E. K., 1994, Fractionation sensitivity (alpha/beta ratio) of human melanoma xenografts. Radiotherapy and Oncology, 33, 133-138.
85. SAUNDERS, M. I., DISCHE, S., BARRETT, A., PARMAR, M. K., HARVEY, A. and GIBSON, D., 1996, Randomised multi centre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee. British Journal of Cancer, 73, 1455-1462.
86. SAUSE, W. T., COOPER, J. S., RUSH, S., AGO, C. T., COSMATOS, D., COUGHLIN, C. T., JANJAN, N. and LIPSETT, J., 1991, Fraction size in external beam radiation therapy in the treatment of melanoma. International Journal of Radiation Oncology, Biology, Physics, 20, 429-432.
87. SCOTT, D., SPREADBOROUGH, A. R., JONES, L. A., ROBERTS, S. A. and MOORE, C. J., 1996, Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiation Research, 145, 3-16.
88. SHIRATO, H., MIZUTA, M. and MIYASAKA, K., 1995, A mathematical model of the volume effect which postulates cell migration from unirradiated tissues. Radiotherapy and Oncology, 35, 227-231.
89. SKLADOWSKI, K., LAW, M. G., MACIEJEWSKI, B. and STEEL, G. G., 1994, Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiotherapy and Oncology, 30, 109-120.
90. SLEVIN, N. J., HENDRY, J. H., ROBERTS, S. A. and AGREN-CRONQVIST A., 1992, The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiotherapy and Oncology, 24, 215-220.
91. SPIJKERVET, F. K. L., VAN SAENE, H. K. F., VAN SAENE, J. J. M., PANDERS, A. K., VERMEY, A. and MEHTA, D. M., 1991, Mucositis prevented by selective elimination of oral flora in irradiated head and neck cancer patients. Journal of Oral Pathological Medicine, 19, 486-489.
92. STEWART, F. A. and SAUNDERS, M. I., 1997, Combined radiotherapy and chemotherapy: clinical application and evaluation. In Basic Clinical Radiobiology, edited by G. G. Steel (London: Arnold), pp. 195-202.
93. STRANG, P., EKLUND, G., STENDAHL, U. and FRANKENDAL, B., 1987, S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix. Anticancer Research, 7, 807-810.
94. STUBEN, G., VAN DER KOGEL, A. J. and VAN DER SCHUEREN, E., 1997, Biological equivalence of low dose rate to multi fractionated high dose rate irradiation: investigations in mouse lip mucosa. Radiotherapy and Oncology, 42, 189-196.
95. STUSCHKE, M. D. and THAMES, H. D., 1997, Hyperfractionated radiotherapy of human tumours: overview of the randomized clinical trials. International Journal of Radiation Oncology, Biology, Physics, 37, 259-267.
96. SURESH, A., TUNG, F., MOREB, J. and ZUCALI, J. R., 1994, Role of manganese superoxide dismutase in radioprotection using gene transfer studies. Cancer Gene Therapy, 1, 85-90.
97. SYMONDS, R. P., MCILROY, P., KHORRAMI, J., PYPER, E., ALCOCK, S. R., MCCALLUM, A., SPEEKENBRINK, A. B. J., MCMURRAY, A., LINDEMANN, E. and THOMAS, M., 1996, The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. British Journal of Cancer, 74, 3112-3117.
98. TAIT, D. M., NAHUM, A. E., MEYER, L. C., LAW, M., DEARNALEY, D. P., HORWICH, A., MAYLES, W. P. and YARNOLD, J. R., 1997, Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiotherapy and Oncology, 42, 121-136.
99. THAMES, H. D., 1984 Effect-independent measures of tissue responses to fractionated irradiation. International Journal of Radiation Biology, 45, 1-10.
100. THAMES, H. D., BENTZEN, S. M., TURESSON, I., OVERGAARD, M. and VAN DEN BOGAERT, W., 1989, Fractionation parameters for human tissues and tumours. International Journal of Radiation Biology, 56, 701-710.
101. THAMES, H. D., BENTZEN, S. M., TURESSON, I., OVERGAARD, M. and VAN DEN BOGAERT, W., 1990, Time dose factors in radiotherapy: a review of the human data. Radiotherapy and Oncology, 19, 219-235.
102. THAMES, H. D. and HENDRY, J. H., 1987, Fractionation in Radiotherapy (London: Taylor & Francis).
103. THAMES, H. D., SCHULTHEISS, T. E., HENDRY, J. H., TUCKER, S. L., DUBRAY, B. M. and BROCK, W. A., 1991, Can modest escalations of dose be detected as increased tumour control? International Journal of Radiation Oncology, Biology, Physics, 22, 241-246.
104. THAMES, H. D. and SUIT, H. D., 1986, Tumor radioresponsiveness versus fractionation sensitivity. International Journal of Radiation Oncology, Biology, Physics, 12, 687-691.
105. TOBIAS, J. S., 1994 Chemotherapy-radiotherapy combinations for advanced head and neck cancer. In Current Topics in Radiation Oncology, Vol. 1, edited by J. S. Tobias and P. R. M. Thomas (London: Arnold), pp. 231-249.
106. TROTT, K. R., 1993, The fractionation sensitivity of malignant melanoma. In Current Topics in Clinical Radiobiology of Tumours, edited by H. P. Beck-Bornholdt (Berlin: Springer-Verlag), pp. 76-85.
107. TROTT, K. and KUMMERMEHR, J., 1993, The time factor and repopulation in tumours and normal tissues. Seminars in Radiotherapy and Oncology, 3, 115-125.
108. TSANG, R. W., FYLES, A. W., KIRKBRIDGE, P., LEVIN, W., MANCHUL, I., MILOSOVIC, M., RAWLINGS, G., BAHERJEE, D., PINTILIE, M. and WILSON, G., 1995, Proliferation measurement with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. International Journal of Radiation Oncology, Biology, Physics, 32, 1319-1329.
109. TUCKER, S. L., GEARA, F. B., PETERS, L. J. and BROCK, W. A., 1996, How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiotherapy and Oncology, 38, 103-113.
110. TUCKER, S. L. and THAMES, H. D., 1989, The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. International Journal of Radiation Oncology, Biology, Physics, 17, 145-147.
111. TUCKER, S. L, THAMES, H. D. and TAYLOR, J. M., 1990, How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiation Research, 124, 273-282.
112. TURESSON, I. and JOINER, M. C., 1996, Clinical evidence of hypersensitivity to low doses in radiotherapy. Radiotherapy and Oncology, 40, 1-3.
113. TURESSON, I. and THAMES, H. D., 1989, Repair capacity of human skin during fractionated radiotherapy: erythema, desquamation and telangiectasia after 3 and 5 years' follow-up. Radiotherapy and Oncology, 15, 169-188.
114. TURNER, S. L., SLEVIN, N. J., GUPTA, N. K. and SWINDELL, R., 1996, Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity - evaluation of late morbidity and a watch policy for the clinically negative neck. Radiotherapy and Oncology, 41, 21-29.
115. WEICHSELBAUM, R. R., 1991, Possible applications of biotechnology to radiotherapy. European Journal of Cancer, 27, 405-407.
116. WEST, C. M. L., DAVIDSON, S. E., BURT, P. A. and HUNTER, R. D., 1995, The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. International Journal of Radiation Oncology, Biology, Physics, 15, 841-846.
117. WEST, C. M. L., DAVIDSON, S. E., ROBERTS, S. A. and HUNTER, R. D., 1993. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. British Journal of Cancer, 68, 819-823.
118. WITHERS, H. R., TAYLOR, J. M. G. and MACIEWJEWSKI, B., 1988a, The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica, 27, 131-146.
119. WITHERS, H. R., TAYLOR, J. M. and MACIEJEWSKI, B., 1988b, Treatment volume and tissue tolerance. International Journal of Radiation Oncology, Biology, Physics, 14, 751-759.
120. YAES, R. J. and KALEND, A., 1988, Local stem cell depletion model for radiation myelitis. International Journal of Radiation Oncology, Biology, Physics, 14, 1247-1259.
121. ZACKRISSON, B., GUSTAFSSON, H., STENLING, R., FLYGARE, P. and WILSON, G. D., 1997, Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 38, 677-683.
122. ZAGARS, G. K., SCHULTHEISS, T. E. and PETERS, L. J., 1987, Inter-tumour heterogeneity and radiation dose-control curves. Radiotherapy and Oncology, 8, 353-362.